Literature DB >> 15838590

gamma-L-glutamyltaurine.

S Bittner1, T Win, R Gupta.   

Abstract

The discovery of the dipeptide gamma-glutamyltaurine (gamma-GT; glutaurine, Litoralon) in the parathyroid in 1980 and later in the brain of mammals gave rise to studies on intrinsic and synthetic taurine peptides of this type. It was suggested that gamma-glutamyltransferase (GGT; gamma-glutamyltranspeptidase) in the brain is responsible for the in vivo formation of this unusual dipeptide. gamma-GT has been prepared by both synthetic and enzymatic methods. The chemical syntheses included the use of protecting groups and coupling methods. A wide spectrum of analytical and spectroscopic methods was used to confirm the structure of the synthetic compounds and to elucidate the position of the peptide bond. Enzymatic preparation of gamma-GT from taurine takes advantage of the selective transpeptidation action of GGT on L-glutamine, glutathione, gamma-glutamyl-p-nitroanilide or other glutamine donors. Although the functional roles of gamma-GT in the brain are only poorly understood, many of its established CNS effects have been reported in the last 25 years. Its effect on emotional arousal and its anti-conflict potencies are synergistic with the anxiolytic drug diazepam. gamma-GT exhibits anti-conflict potency, which is exerted by reducing aversion or phobia and/or the anxiety levels. gamma-GT also acts as endogenous modulator in excitatory aminoacidergic neurotransmission. It is suggested that such acidic peptides through N-methyl-D-aspartic acid receptors could be part of the neurochemical substrate underlying self-stimulation of the medial prefrontal cortex. Other gamma-GT effects in neural systems include: effects on the monoamine concentration in the brain; effects on aggressive behavior in the cat; effects on thyroid hormones in the rat; amelioration of electroshock-induced amnesia; potent and long-lasting antiepileptic action (on intra-amygdaloid injection); affect the glutamatergic system in schizophrenic disorders. Roles for gamma-GT in non-neural systems have also been reported, e.g., effects on the metamorphosis of amphibians; on plasma rennin regulation; on radiation protection; on uric acid levels; on human antibody-dependent cell-mediated cytotoxicity (ADCC) and many more.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838590     DOI: 10.1007/s00726-005-0196-7

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

1.  Gamma-glutamyl compounds: substrate specificity of gamma-glutamyl transpeptidase enzymes.

Authors:  Stephanie Wickham; Matthew B West; Paul F Cook; Marie H Hanigan
Journal:  Anal Biochem       Date:  2011-03-27       Impact factor: 3.365

2.  UPLC-G2Si-HDMS Untargeted Metabolomics for Identification of Yunnan Baiyao's Metabolic Target in Promoting Blood Circulation and Removing Blood Stasis.

Authors:  Qingyu Zhang; Aihua Zhang; Fangfang Wu; Xijun Wang
Journal:  Molecules       Date:  2022-05-17       Impact factor: 4.927

3.  The human gamma-glutamyltransferase gene family.

Authors:  Nora Heisterkamp; John Groffen; David Warburton; Tam P Sneddon
Journal:  Hum Genet       Date:  2008-03-21       Impact factor: 4.132

4.  Isolation and Total Synthesis of Stolonines A-C, Unique Taurine Amides from the Australian Marine Tunicate Cnemidocarpa stolonifera.

Authors:  Trong D Tran; Ngoc B Pham; Merrick Ekins; John N A Hooper; Ronald J Quinn
Journal:  Mar Drugs       Date:  2015-07-22       Impact factor: 5.118

Review 5.  Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.

Authors:  Md Jakaria; Shofiul Azam; Md Ezazul Haque; Song-Hee Jo; Md Sahab Uddin; In-Su Kim; Dong-Kug Choi
Journal:  Redox Biol       Date:  2019-05-21       Impact factor: 11.799

6.  Advances in drug design based on the amino Acid approach: taurine analogues for the treatment of CNS diseases.

Authors:  Man Chin Chung; Pedro Malatesta; Priscila Longhin Bosquesi; Paulo Renato Yamasaki; Jean Leandro Dos Santos; Ednir Oliveira Vizioli
Journal:  Pharmaceuticals (Basel)       Date:  2012-10-23

7.  Modeling tissue-relevant Caenorhabditis elegans metabolism at network, pathway, reaction, and metabolite levels.

Authors:  Lutfu Safak Yilmaz; Xuhang Li; Shivani Nanda; Bennett Fox; Frank Schroeder; Albertha Jm Walhout
Journal:  Mol Syst Biol       Date:  2020-10       Impact factor: 11.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.